Patent details

EP3283107 Title: COMPOSITIONS COMPRISING A COMBINATION OF IPILIMUMAB AND NIVOLUMAB

Basic Information

Publication number:
EP3283107
PCT Application Number:
US2016027913
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP167188358
PCT Publication Number:
WO2016168716
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMPOSITIONS COMPRISING A COMBINATION OF IPILIMUMAB AND NIVOLUMAB
French Title of Invention:
COMPOSITIONS COMPRENANT UNE COMBINAISON DE IPILIMUMAB ET NIVOLUMAB
German Title of Invention:
ZUSAMMENSETZUNGEN MIT EINER KOMBINATION AUS IPILIMUMAB UND NIVOLUMAB
SPC Number:

Dates

Filing date:
15/04/2016
Grant date:
27/05/2020
EP Publication Date:
21/02/2018
PCT Publication Date:
20/10/2016
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
27/05/2020
EP B1 Publication Date:
27/05/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
15/04/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
20/05/2020
 
 

Name:
Bristol-Myers Squibb Company
Address:
Route 206 and Province Line Road, Princeton, NJ 08543, United States (US)

Agent

Name:
MARKS & CLERK LLP
From:
10/07/2020
Address:
BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
To:

Inventor

1

Name:
QUAN, Yong
Address:
United States (US)

2

Name:
SADINENI, Vikram
Address:
United States (US)

3

Name:
KASERER, Wallace
Address:
United States (US)

Priority

1

Priority Number:
201562149325 P
Priority Date:
17/04/2015
Priority Country:
United States (US)

2

Priority Number:
201562265268 P
Priority Date:
09/12/2015
Priority Country:
United States (US)

3

Priority Number:
201562269000 P
Priority Date:
17/12/2015
Priority Country:
United States (US)

4

Priority Number:
201662303855 P
Priority Date:
04/03/2016
Priority Country:
United States (US)

Classification

IPC classification:
A61K 39/395; C07K 16/28;

Publication

European Patent Bulletin

Issue number:
202022
Publication date:
27/05/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
30/04/2026
Annual Fee Number:
11
Annual Fee Amount:
148 Euro
Expected Payer:
Last Annual Fee Payment Date:
16/04/2025
Last Annual Fee Paid Number:
10
Last Annual Fee Paid Amount:
131 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
15/07/2020 Outgoing Correspondence 1
10/07/2020 Power Of Attorney 1
12/08/2022 Request For Change 1
02/09/2022 Outgoing Correspondence 56